Skip to content
FTHFTH
Prostate Cancer · 前立腺がん

Prostate Cancer

Insurance-coveredClinical trial

Basic Information

Fractions
12 fractions, 3 weeks
Description
Localized and locally advanced prostate cancer without metastasis (T1b–T4 N0 M0) is covered by insurance. Recurrence after radical prostatectomy or after hormone therapy is not eligible.
Source: QST Hospital 「重粒子線治療の適応」 — View original ↗

Related Articles

1articles
2026.10.11

Carbon Ion Therapy for Prostate Cancer: Eligibility, Combined Hormone Therapy, 12 Fractions over 3 Weeks, and Side Effects (Summary of QST Hospital Materials)

Prostate cancer and carbon ions

With the spread of PSA testing, the number of prostate cancer patients is increasing. Curative treatment for localized prostate cancer is surgery or radiotherapy, with hormone therapy combined depending on the condition. QST Hospital has provided carbon ion therapy since 1994, reducing the number of fractions from 20 (5 weeks) to 16 (4 weeks) and 12 (3 weeks). It has been covered by insurance in Japan since April 2018.

Learn More
← PreviousBone and Soft Tissue TumorsFull listNext →Esophageal Cancer